• EI
  • Scopus
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
  • DOAJ
  • EBSCO
  • 北大核心期刊
  • 中国核心学术期刊RCCSE
  • JST China
  • FSTA
  • 中国精品科技期刊
  • 中国农业核心期刊
  • CA
  • WJCI
  • 中国科技核心期刊CSTPCD
  • 中国生物医学SinoMed
中国精品科技期刊2020
王引,张兰威. 益生菌联合白藜芦醇对小鼠慢性酒精性肝损伤的改善作用及机制研究[J]. 食品工业科技,2022,43(5):374−380. doi: 10.13386/j.issn1002-0306.2021070170.
引用本文: 王引,张兰威. 益生菌联合白藜芦醇对小鼠慢性酒精性肝损伤的改善作用及机制研究[J]. 食品工业科技,2022,43(5):374−380. doi: 10.13386/j.issn1002-0306.2021070170.
WANG Yin, ZHANG Lanwei. Ameliorative Effect and Mechanism of Probiotics Combined with Resveratrol on Chronic Alcoholic Liver Injury in Mice[J]. Science and Technology of Food Industry, 2022, 43(5): 374−380. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021070170.
Citation: WANG Yin, ZHANG Lanwei. Ameliorative Effect and Mechanism of Probiotics Combined with Resveratrol on Chronic Alcoholic Liver Injury in Mice[J]. Science and Technology of Food Industry, 2022, 43(5): 374−380. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021070170.

益生菌联合白藜芦醇对小鼠慢性酒精性肝损伤的改善作用及机制研究

Ameliorative Effect and Mechanism of Probiotics Combined with Resveratrol on Chronic Alcoholic Liver Injury in Mice

  • 摘要: 利用C57BL/6J小鼠构建慢性酒精性肝损伤模型,探究益生菌联合白藜芦醇对慢性酒精性肝损伤的保护作用及可能机制。小鼠被随机分为空白对照组(Con组)和酒精模型组(Mod组),三组益生菌分别联合白藜芦醇(Resveratrol,Res)干预组(Lactobacillus paracasei J5+Res(J5+Res)、Lactobacillus casei YRL577+Res(YRL577+Res)、Bifidobacterium animalis F1-7+Res(F1-7+Res))和阳性药物硫普罗宁组(LP组)。实验结束后,通过分析小鼠肝脏脂质含量、酒精代谢酶活性、氧化应激水平等指标,对益生菌联合白藜芦醇的作用效果进行评价。为了进一步探究联合作用机制,对肝脏中氧化应激相关基因CYP2E1、核因子 E2 相关因子 2(Nuclear factor erythroid-2-related factor 2, Nrf2)、血红素加氧酶1(Heme oxygenase-1,HO-1)的mRNA表达进行分析。结果表明,相较于Mod组,益生菌联合白藜芦醇能够显著降低小鼠肝脏中甘油三脂、总胆固醇含量、血清谷草转氨酶和谷丙转氨酶活力(P<0.05),提高肝脏乙醇脱氢酶、乙醛脱氢酶活性并抑制肝脏CYP2E1活性及其mRNA表达,显著提高肝脏还原型谷胱甘肽含量和超氧化物歧化酶、过氧化氢酶活性(P<0.05),并能有效激活Nrf2/HO-1通路,其中,Nrf2 mRNA表达量在J5+Res、YRL577+Res、F1-7+Res三组益生菌联合干预组中分别被上调了2.6、3.7和2.7倍,HO-1 mRNA表达量被上调了2.0、6.2和4.0倍。因此,益生菌联合白藜芦醇可能通过激活Nrf2/HO-1途径预防慢性酒精性肝损伤。

     

    Abstract: To explore the protective effect and possible mechanism of probiotics combined with resveratrol on chronic alcoholic liver injury, C57BL/6J mice were used to construct chronic alcoholic liver injury model. Mice were randomly divided into the control group (Con group), themodel group (Mod group), three intervention groups of probiotics combined with resveratrol (Res) (Lactobacillus paracasei J5+Res (J5+Res), Lactobacillus casei YRL577+Res (YRL577+Res), Bifidobacterium animalis F1-7+Res (F1-7+Res)) groups, and the positive drug tiopronin group (LP group). After the experiment, the liver lipid content, alcohol metabolism enzyme activities, oxidative stress level and other indexes of mice were investigated. In order to further explore the mechanism of the combined action, the mRNA expressions of oxidative stress related genes CYP2E1, nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) in liver were analyzed. The results showed that compared with Mod group, probiotics combined with resveratrol could significantly reduce the contents of triglyceride, total cholesterol, serum aspartate aminotransferase and alanine aminotransferase activites in liver of mice (P<0.05), increase the activities of alcohol metabolism enzymes alcohol dehydrogenase and acetaldehyde dehydrogenase in liver, inhibit the activity of CYP2E1 and its mRNA expression in liver. In addition, the contents of glutathione as well as the activities of superoxide dismutase and catalase in liver significantly increased (P<0.05), the Nrf2/HO-1 pathway was effectively activated compared with Mod group (P<0.05). Nrf2 mRNA expression was up-regulated by 2.6, 3.7 and 2.7 times in J5+Res, YRL577+Res and F1-7+Res groups, and HO-1 was up-regulated by 2.0, 6.2 and 4.0 times, respectively. Therefore, probiotics combined with resveratrol mayprevente chronic alcoholic liver injury through the Nrf2/HO-1 pathway.

     

/

返回文章
返回